These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37956676)

  • 41. Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.
    Chen H; Tucker J; Wang X; Gavine PR; Phillips C; Augustin MA; Schreiner P; Steinbacher S; Preston M; Ogg D
    Acta Crystallogr D Struct Biol; 2016 May; 72(Pt 5):682-93. PubMed ID: 27139631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies.
    Bhujbal SP; He W; Hah JM
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serine/Threonine Protein Kinases as Attractive Targets for Anti-Cancer Drugs-An Innovative Approach to Ligand Tuning Using Combined Quantum Chemical Calculations, Molecular Docking, Molecular Dynamic Simulations, and Network-like Similarity Graphs.
    Latosińska M; Latosińska JN
    Molecules; 2024 Jul; 29(13):. PubMed ID: 38999151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations.
    Shafie A; Khan S; Zehra ; Mohammad T; Anjum F; Hasan GM; Yadav DK; Hassan MI
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy.
    Mohammad T; Batra S; Dahiya R; Baig MH; Rather IA; Dong JJ; Hassan I
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31847444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
    Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
    Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An in silico protocol for identifying mTOR inhibitors from natural products.
    Chen L; Wang L; Gu Q; Xu J
    Mol Divers; 2014 Nov; 18(4):841-52. PubMed ID: 25156384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules.
    Vanajothi R; Vedagiri H; Al-Ansari MM; Al-Humaid LA; Kumpati P
    J Biomol Struct Dyn; 2022 May; 40(8):3385-3399. PubMed ID: 33200682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. circBTBD7 Promotes Immature Porcine Sertoli Cell Growth through Modulating miR-24-3p/
    Bian Q; Chen B; Weng B; Chu D; Tang X; Yan S; Yin Y; Ran M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.
    Badrinarayan P; Sastry GN
    J Mol Graph Model; 2012 Apr; 34():89-100. PubMed ID: 22306417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
    Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach.
    Shafique S; Bibi N; Rashid S
    J Theor Biol; 2016 Jan; 388():72-84. PubMed ID: 26493360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of high-affinity pyridoxal kinase inhibitors targeting cancer therapy: an integrated docking and molecular dynamics simulation approach.
    Banerjee P; Chandra A; Mohammad T; Singh N; Hassan MI; Qamar I
    J Biomol Struct Dyn; 2024 Oct; 42(16):8523-8540. PubMed ID: 37578056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of novel modulators targeting human TRPC5: Docking-based virtual screening, molecular dynamics simulation and binding affinity predication.
    Liu B; Zhang W; Guo S; Zuo Z
    J Mol Graph Model; 2021 Jan; 102():107795. PubMed ID: 33161371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of potential ATP-competitive cyclin-dependent kinase 1 inhibitors: De novo drug generation, molecular docking, and molecular dynamics simulation.
    He F; Wang X; Wu Q; Liu S; Cao Y; Guo X; Yin S; Yin N; Li B; Fang M
    Comput Biol Med; 2023 Mar; 155():106645. PubMed ID: 36774892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
    Sharma A; Thelma BK
    J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Scaffold-based Screening and Molecular Dynamics Simulation Study to Identify Two Structurally Related Phenolic Compounds as Potent MMP1 Inhibitors.
    Patra S; Saravanan P; Das B; Subramanian V; Patra S
    Comb Chem High Throughput Screen; 2020; 23(8):757-774. PubMed ID: 32342802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine/threonine kinase: integrating computational modeling and molecular dynamics simulation.
    Patel M; Bazaid AS; Azhar EI; Gattan HS; Binsaleh NK; Patel M; Surti M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):13679-13695. PubMed ID: 36852556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.